• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度尼西亚重症监护病房患者急性肾损伤的发生率和肾脏替代治疗的应用。

Incidence of acute kidney injury and use of renal replacement therapy in intensive care unit patients in Indonesia.

机构信息

Division of Nephrology, Department of Internal Medicine, Gatot Soebroto Indonesia Central Army Hospital, Jakarta, Indonesia.

Department of Anesthesiology and Reanimation, Gatot Soebroto Indonesia Central Army Hospital, Jakarta, Indonesia.

出版信息

BMC Nephrol. 2020 May 20;21(1):191. doi: 10.1186/s12882-020-01849-y.

DOI:10.1186/s12882-020-01849-y
PMID:32434496
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7238547/
Abstract

BACKGROUND

Currently, there is limited epidemiology data on acute kidney injury (AKI) in Indonesia. Therefore, we assessed the incidence of AKI and the utilization of renal replacement therapy (RRT) in Indonesia.

METHODS

Demographic and clinical data were collected from 952 ICU participants. The participants were categorized into AKI and non-AKI groups. The participants were further classified according to the 3 different stages of AKI as per the Kidney Disease Improving Global Outcome (KDIGO) criteria.

RESULTS

Overall incidence of AKI was 43%. The participants were divided into three groups based on the AKI stages: 18.5% had stage 1, 33% had stage 2, and 48.5% had stage 3. Primary diagnosis of renal disease and high APACHE II score were the risk factors associated with AKI (OR = 4.53, 95% CI: 1.67-12.33, p = 0.003 and OR = 1.14 per 1 unit increase, 95% CI: 1.09-1.20, p < 0.001, respectively). Chronic kidney disease was the risk factor for severe AKI. Sepsis was the leading cause of AKI. Among the AKI participants, 24.6% required RRT. The most common RRT modalities were intermittent hemodialysis (71.7%), followed by slow low-efficiency dialysis (22.8%), continuous renal replacement therapy (4.3%), and peritoneal dialysis (1.1%).

CONCLUSIONS

This study showed that AKI was a common problem in the Indonesian ICU. We strongly believe that identification of the risk factors associated with AKI will help us develop a predictive score for AKI so we can prevent and improve AKI outcome in the future.

摘要

背景

目前,印度尼西亚关于急性肾损伤(AKI)的流行病学数据有限。因此,我们评估了印度尼西亚 AKI 的发生率和肾脏替代治疗(RRT)的应用情况。

方法

从 952 名 ICU 参与者中收集人口统计学和临床数据。将参与者分为 AKI 组和非 AKI 组。根据 KDIGO 标准,将参与者进一步分为 AKI 的 3 个不同阶段。

结果

AKI 的总发生率为 43%。根据 AKI 分期,将参与者分为三组:1 期占 18.5%,2 期占 33%,3 期占 48.5%。肾脏疾病的主要诊断和较高的 APACHE II 评分是 AKI 的危险因素(OR=4.53,95%CI:1.67-12.33,p=0.003 和 OR=每增加 1 单位增加 1.14,95%CI:1.09-1.20,p<0.001)。慢性肾脏病是严重 AKI 的危险因素。脓毒症是 AKI 的主要原因。在 AKI 参与者中,24.6%需要 RRT。最常见的 RRT 方式是间歇性血液透析(71.7%),其次是缓慢低效透析(22.8%)、连续肾脏替代治疗(4.3%)和腹膜透析(1.1%)。

结论

本研究表明 AKI 是印度尼西亚 ICU 中的常见问题。我们坚信,确定与 AKI 相关的危险因素将有助于我们开发 AKI 的预测评分,以便我们能够预防和改善未来 AKI 的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c5/7238547/9da94f7ea1ec/12882_2020_1849_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c5/7238547/a14b70b97b09/12882_2020_1849_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c5/7238547/9da94f7ea1ec/12882_2020_1849_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c5/7238547/a14b70b97b09/12882_2020_1849_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c5/7238547/9da94f7ea1ec/12882_2020_1849_Fig2_HTML.jpg

相似文献

1
Incidence of acute kidney injury and use of renal replacement therapy in intensive care unit patients in Indonesia.印度尼西亚重症监护病房患者急性肾损伤的发生率和肾脏替代治疗的应用。
BMC Nephrol. 2020 May 20;21(1):191. doi: 10.1186/s12882-020-01849-y.
2
Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT).前瞻性多中心 ICU 急性肾损伤流行病学研究:重症肾脏科意大利协作研究(NEFROINT)。
Minerva Anestesiol. 2011 Nov;77(11):1072-83. Epub 2011 May 11.
3
Clinical characteristics and outcome of critically ill COVID-19 patients with acute kidney injury: a single centre cohort study.COVID-19 危重症患者合并急性肾损伤的临床特征和转归:一项单中心队列研究。
BMC Nephrol. 2021 Mar 15;22(1):92. doi: 10.1186/s12882-021-02296-z.
4
[Effect of early initiation of continuous renal replacement therapy based on the KDIGO classification on the prognosis of critically ill patients with acute kidney injury].基于KDIGO分类的早期启动连续性肾脏替代治疗对急性肾损伤危重症患者预后的影响
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016 Mar;28(3):246-51.
5
Acute Kidney Injury and Renal Replacement Therapy in Critically Ill COVID-19 Patients: Risk Factors and Outcomes: A Single-Center Experience in Brazil.急性肾损伤和危重症 COVID-19 患者的肾脏替代治疗:危险因素和结局:巴西单中心经验。
Blood Purif. 2021;50(4-5):520-530. doi: 10.1159/000513425. Epub 2020 Dec 18.
6
[Clinical characteristics and prognosis of acute kidney injury in elderly patients with sepsis].[老年脓毒症患者急性肾损伤的临床特征与预后]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Jul;31(7):837-841. doi: 10.3760/cma.j.issn.2095-4352.2019.07.008.
7
Risk factors of acute kidney injury requiring renal replacement therapy based on regional registry data.基于区域登记数据的需要肾脏替代治疗的急性肾损伤的危险因素
Anaesthesiol Intensive Ther. 2016;48(3):185-90. doi: 10.5603/AIT.a2016.0033.
8
[An analysis of clinical characteristics of septic acute kidney injury by using criteria of Kidney Disease: Improving Global Outcomes].[应用《改善全球肾脏病预后组织》标准分析脓毒症急性肾损伤的临床特征]
Zhonghua Nei Ke Za Zhi. 2013 Apr;52(4):299-304.
9
Long-term outcome in ICU patients with acute kidney injury treated with renal replacement therapy: a prospective cohort study.接受肾脏替代治疗的急性肾损伤重症监护病房患者的长期预后:一项前瞻性队列研究。
Crit Care. 2016 Aug 12;20(1):256. doi: 10.1186/s13054-016-1409-z.
10
Factors Associated with Mortality of Intensive Care Unit Patients with Acute Kidney Injury at Cipto Mangunkusumo National Central General Hospital.雅加达中央陆军医院重症监护病房急性肾损伤患者死亡率的相关因素。
Acta Med Indones. 2019 Oct;51(4):324-330.

本文引用的文献

1
The epidemiology and characteristics of acute kidney injury in the Southeast Asia intensive care unit: a prospective multicentre study.东南亚重症监护病房急性肾损伤的流行病学和特征:一项前瞻性多中心研究。
Nephrol Dial Transplant. 2020 Oct 1;35(10):1729-1738. doi: 10.1093/ndt/gfz087.
2
Epidemiology of acute kidney injury and chronic kidney disease in the intensive care unit.重症监护病房中急性肾损伤和慢性肾脏病的流行病学
Rev Bras Ter Intensiva. 2017 Oct-Dec;29(4):444-452. doi: 10.5935/0103-507X.20170061. Epub 2017 Nov 30.
3
Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup.
急性肾损伤与肾脏恢复:急性疾病质量倡议(ADQI)16 工作组的共识报告。
Nat Rev Nephrol. 2017 Apr;13(4):241-257. doi: 10.1038/nrneph.2017.2. Epub 2017 Feb 27.
4
International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology.国际肾脏病学会的急性肾损伤“2025 零可预防死亡”倡议:肾脏病学的人权案例
Lancet. 2015 Jun 27;385(9987):2616-43. doi: 10.1016/S0140-6736(15)60126-X. Epub 2015 Mar 13.
5
Acute kidney injury in a Malaysian intensive care unit: Assessment of incidence, risk factors, and outcome.马来西亚重症监护病房中的急性肾损伤:发病率、危险因素及预后评估
J Crit Care. 2015 Jun;30(3):636-42. doi: 10.1016/j.jcrc.2015.01.018. Epub 2015 Jan 29.
6
Variation in risk and mortality of acute kidney injury in critically ill patients: a multicenter study.危重症患者急性肾损伤的风险及死亡率差异:一项多中心研究
Am J Nephrol. 2015;41(1):81-8. doi: 10.1159/000371748. Epub 2015 Feb 10.
7
Acute kidney injury: definition, epidemiology, and outcome.急性肾损伤:定义、流行病学和结局。
Curr Opin Crit Care. 2011 Dec;17(6):548-55. doi: 10.1097/MCC.0b013e32834cd349.
8
A comparison of three methods to estimate baseline creatinine for RIFLE classification.三种估算 RIFLE 分类基线肌酐的方法比较。
Nephrol Dial Transplant. 2010 Dec;25(12):3911-8. doi: 10.1093/ndt/gfp766. Epub 2010 Jan 25.
9
Acute kidney injury in the intensive care unit: an update and primer for the intensivist.重症监护病房中的急性肾损伤:重症医师的更新与入门。
Crit Care Med. 2010 Jan;38(1):261-75. doi: 10.1097/CCM.0b013e3181bfb0b5.
10
Incidence and outcomes of acute kidney injury in intensive care units: a Veterans Administration study.重症监护病房中急性肾损伤的发病率及转归:一项退伍军人事务部的研究。
Crit Care Med. 2009 Sep;37(9):2552-8. doi: 10.1097/CCM.0b013e3181a5906f.